Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...
Gespeichert in:
Hovedforfatter: | |
---|---|
Andre forfattere: | |
Format: | Dissertation |
Sprog: | engelsk |
Udgivet: |
Philipps-Universität Marburg
2018
|
Fag: | |
Online adgang: | PDF-Volltext |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
No citations were found for this record.